Rotavirus vaccines.

被引:1
作者
Schmitz, J [1 ]
机构
[1] Hop Necker Enfants Malad, Serv Gastroenterol & Nutr Pediat, F-75743 Paris 15, France
来源
ARCHIVES DE PEDIATRIE | 1999年 / 6卷 / 09期
关键词
rotavirus; rotavirus infections; infantile diarrhea; vaccination;
D O I
10.1016/S0929-693X(99)80593-4
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Rotavirus is the most common cause of severe acute diarrhea, responsible for 30 to 40 deaths of children each year in France In order to decrease both mortality and morbidity, vaccines have been designed first from attenuated bovine strains, then from monovalent simian strains, and more recently from reassortant rhesus strains. The live tetravalent human-rhesus reassortant vaccine (RRT-TV) has been shown to be protective in the United States, Finland, and Venezuela despite different environments, in prospective double-blind studies. This vaccine, as the natural infection, decreases by 50% the risk of acute rotavirus diarrhea and by 70 to 100% the risk of severe diarrhea with dehydration. At the present time, its cost limits its use to developed countries. It was put on the market in the United States in October 1998. The challenge is now to make it available in developing countries. (C) 1999 Elsevier, Paris.
引用
收藏
页码:979 / 984
页数:6
相关论文
共 17 条
[1]   MEDICAL PROGRESS - VIRAL GASTROENTERITIS [J].
BLACKLOW, NR ;
GREENBERG, HB .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (04) :252-264
[2]   Diarrhoea-related morbidity and rotavirus infection in France [J].
Desenclos, JC ;
Rebière, I ;
Letrillard, L ;
Flahault, A ;
Hubert, B .
ACTA PAEDIATRICA, 1999, 88 :42-47
[3]   The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden [J].
Glass, RI ;
Kilgore, PE ;
Holman, RC ;
Jin, SX ;
Smith, JC ;
Woods, PA ;
Clarke, MJ ;
Ho, MS ;
Gentsch, JR .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S5-S11
[4]   Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis [J].
Joensuu, J ;
Koskenniemi, E ;
Pang, XL ;
Vesikari, T .
LANCET, 1997, 350 (9086) :1205-1209
[5]   ROTAVIRUS - THE MAJOR ETIOLOGIC AGENT OF SEVERE INFANTILE DIARRHEA MAY BE CONTROLLABLE BY A JENNERIAN APPROACH TO VACCINATION [J].
KAPIKIAN, AZ ;
FLORES, J ;
HOSHINO, Y ;
GLASS, RI ;
MIDTHUN, K ;
GORZIGLIA, M ;
CHANOCK, RM .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (05) :815-822
[6]   Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children [J].
Kapikian, AZ ;
Hoshino, Y ;
Chanock, RM ;
PerezSchael, I .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S65-S72
[7]   A vaccine against rotavirus - When is too much too much? [J].
Keusch, GT ;
Cash, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (17) :1228-1229
[8]   Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru [J].
Lanata, CF ;
Midthun, K ;
Black, RE ;
Butron, B ;
Huapaya, A ;
Penny, ME ;
Ventura, G ;
Gil, A ;
JettGoheen, M ;
Davidson, BL .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (02) :268-275
[9]   Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela [J].
PerezSchael, I ;
Guntinas, MJ ;
Perez, M ;
Pagone, V ;
Rojas, AM ;
Gonzalez, R ;
Cunto, W ;
Hoshino, Y ;
Kapikian, AZ .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (17) :1181-1187
[10]   Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines [J].
Rennels, MB .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 :S107-S111